Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer
Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced today that Marc Bregman, CPA, has been appointed as Chief Financial Officer (CFO), effective May 17, 2021. Mr. Bregman and will report to Elite's President and CEO, Nasrat Hakim. Mr. Bregman has more than 27 years of financial and operational experience, including positions as Controller at Langan Engineering &...